Henshaw Capital’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,430	Closed	-$737K	–	257
2025 Q3	$737K	Sell	15,430 -5,624	-27%	-$226K	0.03%	134
2025 Q2	$664K	Hold	21,054	–	–	0.03%	202
2025 Q1	$690K	Buy	21,054 +1,413	+7%	+$50.1K	0.03%	182
2024 Q4	$710K	Buy	19,641 +1,740	+10%	+$61.3K	0.03%	161
2024 Q3	$558K	Hold	17,901	–	–	0.02%	208
2024 Q2	$479K	Buy	17,901 +462	+3%	+$13.4K	0.02%	180
2024 Q1	$595K	Hold	17,439	–	–	0.03%	153
2023 Q4	$505K	Hold	17,439	–	–	0.03%	171
2023 Q3	$481K	Buy	17,439 +7,254	+71%	+$221K	0.03%	160
2023 Q2	$306K	Hold	10,185	–	–	0.02%	180
2023 Q1	$369K	Hold	10,185	–	–	0.02%	156
2022 Q4	$363K	Hold	10,185	–	–	0.02%	148
2022 Q3	$345K	Buy	10,185 +1,264	+14%	+$41.1K	0.03%	185
2022 Q2	$258K	Hold	8,921	–	–	0.02%	248
2022 Q1	$288K	Hold	8,921	–	–	0.02%	255
2021 Q4	$260K	Hold	8,921	–	–	0.01%	289
2021 Q3	$238K	Hold	8,921	–	–	0.01%	297
2021 Q2	$275K	Hold	8,921	–	–	0.02%	295
2021 Q1	$234K	Hold	8,921	–	–	0.02%	316
2020 Q4	$224K	Buy	+8,921	New	+$192K	0.02%	313